Kuros Biosciences Ltd

Company Profile

• Business description

  Kuros Biosciences Ltd is a Swiss-based biotech company, focused on developing and commercializing biologic bone graft technologies for musculoskeletal applications, particularly in spine, trauma, extremities, and oncology. It has two reportable segments: i) Medical Devices: This segment includes products such as MagnetOs and Attrax, which are biphasic calcium phosphate (BCP) bone grafts that mimic the porous, trabecular structure of cancellous bone. ii) Legacy Portfolio: This segment includes all non-core products (including Checkmate licensing) that are outside the Group's primary therapeutic focus. The majority of the company's revenue is derived from the Medical Devices segment. Geographically, it generates the maximum revenue from the United States of America.

• Contact

  Wagistrasse 25
  Schlieren
  Zurich8952
  CHE

  T: +41 447334747

  https://www.kurosbio.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Devices

  Fiscal Year End

  31 December 2026

  Employees

  213